The Biggest Barriers to Energy Efficiency for C-Stores

Convenience stores face an uphill battle in becoming more energy efficient. The 24/7 nature of these locations combined with the increasing popularity of electric vehicles means that urgency is growing to remedy this situation. Jon Bolen, CEO of ENTOUCH, explains these challenges for us in more depth.

For more on this topic, check out Jon’s podcast episode where he dives into the challenges and solutions for c-stores.

Jon’s Thoughts:

Well, convenience source traditionally operate 24 7, right? That’s one of the reasons they create this, this convenient value for us is we go there at any point in time. That means they are powering their lights, their H V A C, their refrigeration, their dispensers, 24 7, 365. No one per square foot in the retail space is using more energy than in your local convenience store.

They are based. With trying to drive efficiencies while we want to be there all the time. At the same time, our world’s changing, right? The types of vehicles we’re driving are changing. They are now trying to figure out not how to fuel our big trust, but our EVs. And so their power strategy and their efficiency goals are changing in a very dynamic world.

It’s really important if you operate a convenience store right now to figure out how you’re gonna make it more efficient and create a different. Experience for your customers.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More